stockrow
Friday 6 November 2026
Export VSEE’s income statement to Excel — free account
VSee Health, Inc.
VSEE Healthcare Health Information Services
VSee Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.6 million, up 40.3% from fiscal 2024.
- Revenue
- −53.9%
- EPS
- +109.9%
- Free cash flow
- −257.6%
- Total debt
- +31.6%
Quarter to June 2026, against a year earlier
1.15
0.00
0.00%
Follow VSEE
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '17 | |
|---|---|---|---|---|---|---|
Piotroski F-Score |
4 | — | — | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | — | — | — |
Altman Z-Score |
(6.06) | (15.02) | (9.97) | — | — | — |
P/S ratio |
0.52 | 1.33 | 0.00 | — | — | — |
Altman Z″-Score (non-manufacturers) |
(16.83) | (37.18) | (92.01) | — | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | — | — | — |
Beneish M-Score |
(4.22) | (13.92) | — | — | — | — |
P/Operating CF |
(3.92) | (4.67) | (1,117.22) | — | — | — |
P/B ratio |
1.38 | 0.00 | 0.00 | — | — | — |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | — | — | — |
EV/Sales |
0.21 | 1.36 | 0.00 | — | — | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | — | — | — |
EV/Operating CF |
(0.89) | (2.45) | (192.67) | — | — | — |
EV/FCF |
(0.88) | (2.42) | (191.37) | — | — | — |
Quick Ratio |
0.48 | 0.11 | 0.14 | 0.03 | 4.13 | — |
Current Ratio |
0.52 | 0.16 | 0.16 | 0.03 | 6.61 | — |
Net Debt/EBITDA |
0.67 | (0.07) | 0.07 | 0.03 | 2.69 | — |
Debt/Assets |
2.65% | 2.97% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.11 | (32.10) | 0.00 | 0.00 | 0.00 | — |
Asset Turnover |
0.69 | 1.00 | 1.37 | 0.00 | 0.00 | — |
Operating CF/Net income |
0.23 | 0.10 | 0.17 | 0.43 | 2.14 | — |
Capex/Depreciation |
(0.01) | 0.00 | (0.05) | — | — | — |
Interest Coverage |
(3.41) | (293.86) | (9.79) | (28.53) | (141.35) | — |
| (541.52%) | 2,672.63% | 64.18% | 60.26% | 0.00% | — | |
| (69.39%) | (554.87%) | (89.17%) | (5.16%) | (0.48%) | — | |
ROIC |
(767.86%) | (15,581.33%) | 0.00% | 0.00% | 0.00% | — |
Return on Tangible Assets |
194.96% | 376.91% | 87.52% | 101.69% | (27.16%) | — |
Average Days of Receivables |
62.94 | 60.12 | 38.20 | — | — | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | — | — | — |
Selling, General and Administrative Expense of Revenue |
115.88% | 113.81% | 97.46% | 0.00% | 0.00% | — |
Intangible Assets out of Total Assets |
0.61 | 0.80 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
7.69% | 8.60% | 0.00% | — | — | — |
Graham Net Nets |
(1.14) | (1.22) | (0.04) | — | — | — |
Graham Number |
0.00 | 31.85 | 151.89 | — | — | — |
Earnings Yield |
(195.10%) | (286.10%) | (3.05%) | — | — | — |
Free Cash Flow Yield |
(46.29%) | (42.07%) | (0.52%) | — | — | — |
Revenue per Share |
58.05 | 81.61 | 46.13 | 0.00 | 0.00 | — |
Operating CF per Share |
(13.68) | (45.34) | (5.06) | (8.73) | (12.05) | — |
Capex per Share |
(0.12) | (0.43) | (0.03) | 0.00 | 0.00 | — |
Free Cash Flow per Share |
(13.80) | (45.77) | (5.10) | (8.73) | (12.05) | — |
Cash per Share |
20.91 | 2.55 | 0.95 | 0.67 | 15.26 | — |
Shareholders Equity per Share |
21.65 | (0.14) | (34.40) | (46.62) | (66.96) | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
21.65 | (0.14) | (34.40) | (46.62) | (66.96) | — |
Free Cash Flow |
(3.48) | (5.84) | (0.64) | (1.39) | (0.60) | — |
Working Capital |
(7.88) | (15.99) | (4.30) | (3.19) | 1.03 | — |
Capital Expenditures |
(0.03) | (0.06) | 0.00 | — | — | — |
Net Current Asset Value |
(8.60) | (16.99) | (4.30) | (14.95) | (120.06) | — |
EV/EBIT |
0.00 | 0.00 | 0.00 | — | — | — |
Capex to Sales |
0.00 | 0.01 | 0.00 | — | — | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | — | — | — |
| Other line items | ||||||
Depreciation/Fixed assets |
7.98 | 85.36 | 25.51 | — | — | — |
Cash ROIC |
(30.72%) | (648.34%) | 15.23% | 19.01% | 23.31% | — |
Accounts Receivable Turnover |
6.90 | 8.98 | 0.00 | — | — | — |
Accounts Payable Turnover |
0.70 | 0.54 | 0.86 | 0.00 | — | — |
Inventory Turnover |
0.00 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
579.84 | 1,051.38 | 488.31 | 0.00 | 0.00 | — |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | — | — | — |
Average Receivables |
2.12 | 1.16 | — | — | — | — |
Average Payables |
10.44 | 5.97 | 2.24 | 1.01 | — | — |
Average Assets |
21.20 | 10.40 | 4.22 | 62.79 | 58.97 | — |
Average Common Equity |
2.72 | (2.16) | (5.86) | (5.38) | — | — |
Columns are period end dates · fundamentals updated 2 Nov 2026